True Wealth Design’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
SLAM
True Wealth Design's BMY Position: Q2 2026 in Review
True Wealth Design increased its Bristol-Myers Squibb (BMY) stake by 2.2% in Q2 2026, buying an estimated $9.47K and bringing the position to 7,785 shares worth $449K. The position accounts for 0.11% of the portfolio, ranked #46.
True Wealth Design first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $462K in Q1 2026. 1,011 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- True Wealth Design held 7,785 shares of Bristol-Myers Squibb worth $449K as of Q2 2026.
- True Wealth Design bought 165 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.47K.
- Bristol-Myers Squibb made up 0.11% of True Wealth Design's portfolio in Q2 2026, its #46 holding.
- True Wealth Design first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
- True Wealth Design's Bristol-Myers Squibb position peaked at $462K in Q1 2026.
- 1,011 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.